Bile acids serve vital functions far beyond traditional lipid emulsification. In recent years, clinicians have recognized them as key endocrine and signaling molecules that regulate systemic metabolism, glucose balance, and inflammatory responses. However, significant serum bile acid variability between individuals often complicates diagnostic accuracy. A landmark investigation by Erngren and colleagues now provides crucial reference data across 24 distinct bile acid species in a large adult cohort. By defining clear reference ranges and identifying non-pathological confounders, this evidence significantly aids diagnostic decision-making.

Understanding Serum Bile Acid Variability and Physiology

Bile acids circulate continuously through the enterohepatic system. Primary forms, such as cholic acid and chenodeoxycholic acid, undergo synthesis directly within hepatocytes. Afterward, gut bacteria transform them into secondary bile acids, including deoxycholic acid and lithocholic acid. Most circulating molecules undergo conjugation with glycine or taurine before secretion. Consequently, these conjugates exhibit higher solubility and distinct signaling properties. Researchers observed that glycine-conjugated forms represent the predominant species in adult human serum. In contrast, primary unconjugated species showed massive concentration differences exceeding 1,000-fold across healthy persons. This profound baseline divergence underscores why single total bile acid measurements often fail to convey complete metabolic health. Furthermore, individual clearance rates and microbiome diversity drive wide swings in systemic concentrations. When physicians evaluate patients for subtle hepatic or metabolic dysfunction, they must recognize that unconjugated fractions naturally display pronounced physiological fluctuations.

Establishing Mass Spectrometry Ranges for 24 Bile Acids

Historically, clinical laboratories evaluated total bile acids using basic enzymatic assays. Although useful for coarse screening, conventional assays lack the resolution needed to profile individual conjugated and unconjugated species. Therefore, the investigative team deployed liquid chromatography coupled with high-resolution mass spectrometry to examine serum from 931 adults. This advanced analytical platform enabled rigorous quantification of 24 distinct bile acid metabolites. Moreover, the investigators successfully established robust population-based reference ranges spanning the 2.5th to 97.5th percentiles. These standardized distributions deliver an invaluable benchmark for hepatologists and internal medicine specialists. Liquid chromatography-high-resolution mass spectrometry eliminates cross-reactivity and provides reproducible quantification even at nanomolar levels. Consequently, clinicians can accurately differentiate between physiological baselines and true pathological elevations. As targeted metabolomics integrates into tertiary medical centers, such granular reference datasets will guide therapeutic monitoring and precision diagnostics.

Demographic Influences: Sex, Age, and Body Mass Index

Demographic characteristics exert a notable influence on circulating bile acid composition. Specifically, the study identified significant sex-specific patterns across multiple fractions. Men exhibited consistently higher levels of unconjugated bile acids compared to women. This divergence likely reflects sex-dependent differences in hepatic enzyme activity and sex hormone regulation. In addition, increasing age and elevated body mass index demonstrated inverse associations with taurine-conjugated bile acids. As individuals age or accumulate adipose tissue, hepatic conjugation efficiency or taurine availability may diminish. Furthermore, weak time-of-day variations occurred among several conjugated species, indicating subtle diurnal shifts. However, these circadian variations remained modest compared to overall interindividual diversity. Consequently, clinicians must interpret subtle alterations in conjugated profiles within the patient's individual demographic framework. Adjusting for age, sex, and weight prevents misclassifying physiological variation as subclinical hepatobiliary disease.

Lifestyle Determinants: The Impact of Smoking and Nicotine

Lifestyle factors directly alter systemic bile acid homeostasis. In this Swedish population study, tobacco use emerged as a particularly strong modifier of circulating metabolites. Researchers quantified tobacco exposure through self-reports and objective serum cotinine measurements. Interestingly, nicotine exposure correlated with reduced circulating conjugated bile acids and an elevation in murideoxycholic acid. Smoking demonstrated far stronger associations with bile acid alterations than alcohol intake or ancestral background. Toxic components in cigarette smoke likely alter hepatic cytochrome P450 enzymes and disrupt normal conjugation pathways. Additionally, chronic nicotine use alters intestinal transit and reshapes the gut microbiota, thereby altering secondary bile acid production. In contrast, moderate alcohol consumption showed surprisingly minimal impact on baseline distributions. Therefore, when evaluating abnormal metabolomic signatures, physicians must rigorously assess active smoking and nicotine exposure before ordering invasive investigations.

Clinical Relevance for Hepatology and Metabolic Care

Accurate profiling of bile acids holds immense diagnostic value across multiple subspecialties. In hepatology, elevated levels serve as critical hallmarks of intrahepatic cholestasis, biliary atresia, and early cirrhosis. Furthermore, gastroenterologists increasingly rely on bile acid panels to diagnose bile acid diarrhea and irritable bowel disorders. In metabolic medicine, altered bile acid signaling through farnesoid X receptors and Takeda G-protein receptor 5 influences insulin sensitivity and steatotic liver disease. However, biomarker utility relies on distinguishing true disease signals from normal physiological variance. Because primary unconjugated species naturally vary by over 1,000-fold, isolated fluctuations might not reflect liver injury. Conversely, unexpected shifts in taurine conjugates could stem from weight gain or advanced age rather than cholestatic damage. Thus, establishing granular reference intervals enables physicians to identify genuine metabolic dysfunction earlier and with greater diagnostic precision.

Frequently Asked Questions

Why does serum bile acid variability matter in clinical evaluation?

Serum bile acid variability is substantial, with unconjugated concentrations differing by more than 1,000-fold among healthy adults. Because baseline concentrations fluctuate widely due to normal physiology, clinicians cannot rely on simplistic cutoffs. High-resolution reference ranges ensure practitioners accurately identify true cholestatic or metabolic pathology while avoiding false-positive diagnoses caused by benign physiological fluctuations.

How do demographic factors such as sex and age influence bile acid levels?

Demographic factors significantly modify baseline bile acid concentrations. Men exhibit significantly higher unconjugated bile acid levels than women, likely due to hormonal differences in hepatic handling. Additionally, advancing age and higher body mass index correlate with reduced levels of taurine-conjugated bile acids. Clinicians must account for these variables when evaluating patient profiles.

What effect does nicotine exposure have on circulating bile acid profiles?

Nicotine exposure markedly alters circulating bile acids, showing stronger associations than alcohol intake. Both active smoking and elevated serum cotinine correlate with reduced conjugated bile acid levels and increased murideoxycholic acid. Tobacco compounds likely impair hepatic conjugation and alter gut microbial metabolism, necessitating careful lifestyle history assessments during diagnostic evaluations.

Disclaimer: This content is for informational and educational purposes only. It is not intended to substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Erngren I et al. Exploring serum bile acid variability: population-based concentration ranges and impact of lifestyle factors in an adult population. Clin Chem Lab Med. 2026 Oct 09. doi: 10.1515/cclm-2026-0809. PMID: 42849040.
2. Li T, Chiang JYL. Bile acid signaling in metabolic and inflammatory diseases and drug development. Pharmacol Rev. 2024;76(6):1221-1253.
3. Di Gioia M, et al. Bile Acids Quantification by Liquid Chromatography–Tandem Mass Spectrometry: Method Validation, Reference Range, and Interference Study. Diagnostics (Basel). 2020;10(7):462.